Reference
1. Blachier M, Leleu H, Peck-Radosavljevic M, Valla DC, Roudot-Thoraval
F. The burden of liver disease in Europe: a review of available
epidemiological data. J Hepatol 2013;58:593-608.
2. Zeng F, Guo P, Huang Y, Xin W, Du Z, Zhu S, Deng Y, et al.
Epidemiology of hepatitis B virus infection: results from a
community-based study of 0.15 million residents in South China.
Scientific reports 2016;6:36186.
3. Ramos-Tovar E, Muriel P. Molecular Mechanisms That Link Oxidative
Stress, Inflammation, and Fibrosis in the Liver. Antioxidants (Basel,
Switzerland) 2020;9.
4. Kisseleva T, Uchinami H, Feirt N, Quintana-Bustamante O, Segovia J,
Schwabe R, Brenner D. Bone marrow-derived fibrocytes participate in
pathogenesis of liver fibrosis. Journal of hepatology 2006;45:429-438.
5. López-Navarrete G, Ramos-Martínez E, Suárez-Álvarez K, Aguirre-García
J, Ledezma-Soto Y, León-Cabrera S, Gudiño-Zayas M, et al. Th2-associated
alternative Kupffer cell activation promotes liver fibrosis without
inducing local inflammation. International journal of biological
sciences 2011;7:1273-1286.
6. Wang L, Wang Y, Quan J. Exosomes derived from natural killer cells
inhibit hepatic stellate cell activation and liver fibrosis. Human cell
2020;33:582-589.
7. Thuy L, Hai H, Kawada N. Role of cytoglobin, a novel radical
scavenger, in stellate cell activation and hepatic fibrosis. Clinical
and molecular hepatology 2020;26:280-293.
8. McQuitty C, Williams R, Chokshi S, Urbani L. Immunomodulatory Role of
the Extracellular Matrix Within the Liver Disease Microenvironment.
Frontiers in immunology 2020;11:574276.
9. de Oliveira C, Martins L, de Sousa A, Moraes K, Costa B, Vieira M,
Coelho B, et al. Resveratrol increases the activation markers and
changes the release of inflammatory cytokines of hepatic stellate cells.
Molecular and cellular biochemistry 2020.
10. Amoras E, Monteiro Gomes S, Freitas Queiroz M, de Araújo M, de
Araújo M, da Silva Conde S, Ishak R, et al. Intrahepatic interleukin 10
expression modulates fibrinogenesis during chronic HCV infection. PloS
one 2020;15:e0241199.
11. Chen H, Awale S, Wu C, Lee H, Wu H. Co-cultured bone marrow
mesenchymal stem cells repair thioacetamide-induced hepatocyte damage.
Cell biology international 2020;44:2459-2472.
12. Van Campenhout S, Van Vlierberghe H, Devisscher L. Common Bile Duct
Ligation as Model for Secondary Biliary Cirrhosis. Methods in molecular
biology (Clifton, N.J.) 2019;1981:237-247.
13. Schreuder A, Busch O, Besselink M, Ignatavicius P, Gulbinas A,
Barauskas G, Gouma D, et al. Long-Term Impact of Iatrogenic Bile Duct
Injury. Digestive surgery 2020;37:10-21.
14. Al-Hashem F, Al-Humayed S, Amin S, Kamar S, Mansy S, Hassan S,
Abdel-Salam L, et al. Metformin inhibits mTOR-HIF-1α axis and
profibrogenic and inflammatory biomarkers in thioacetamide-induced
hepatic tissue alterations. Journal of cellular physiology
2019;234:9328-9337.
15. Mardpour S, Hassani S, Mardpour S, Sayahpour F, Vosough M, Ai J,
Aghdami N, et al. Extracellular vesicles derived from human embryonic
stem cell-MSCs ameliorate cirrhosis in thioacetamide-induced chronic
liver injury. Journal of cellular physiology 2018;233:9330-9344.
16. Intraobserver and interobserver variations in liver biopsy
interpretation in patients with chronic hepatitis C. The French METAVIR
Cooperative Study Group. Hepatology 1994;20:15-20.
17. McGovern A, Vitkovitsky I, Jones D, Mullins M. Can AST/ALT ratio
indicate recovery after acute paracetamol poisoning? Clinical toxicology
(Philadelphia, Pa.) 2015;53:164-167.
18. Welson N, Rofaeil R, Ahmed S, Gaber S, Batiha G, Shahataa M. Vitamin
E protects against gabapentin-induced chronic hepatic and renal damage
associated with the inhibition of apoptosis and tissue injury in rats.
Life sciences 2021;267:118940.
19. Guo T, Liu Z, Zhao Q, Zhao Z, Liu C. A combination of astragaloside
I, levistilide A and calycosin exerts anti-liver fibrosis effects in
vitro and in vivo. Acta pharmacologica Sinica 2018;39:1483-1492.
20. Lee Y, Wallace M, Friedman S. Pathobiology of liver fibrosis: a
translational success story. Gut 2015;64:830-841.
21. Wynn T, Ramalingam T. Mechanisms of fibrosis: therapeutic
translation for fibrotic disease. Nature medicine 2012;18:1028-1040.
22. Yuswan MH, NH AJ, Mohamad H, Keso S, Mohamad NA, Tengku Md Yusoff
TS, Ismail NF, et al. Hydroxyproline determination for initial detection
of halal-critical food ingredients (gelatin and collagen). Food Chem
2021;337:127762.
23. Rantakari P, Patten D, Valtonen J, Karikoski M, Gerke H, Dawes H,
Laurila J, et al. Stabilin-1 expression defines a subset of macrophages
that mediate tissue homeostasis and prevent fibrosis in chronic liver
injury. Proceedings of the National Academy of Sciences of the United
States of America 2016;113:9298-9303.
24. Demirtaş T, Göz E, Karakeçili A, Gümüşderelioğlu M. Combined
delivery of PDGF-BB and BMP-6 for enhanced osteoblastic differentiation.
Journal of materials science. Materials in medicine 2016;27:12.
25. Idemoto K, Ishima T, Niitsu T, Hata T, Yoshida S, Hattori K, Horai
T, et al. Platelet-derived growth factor BB: A potential diagnostic
blood biomarker for differentiating bipolar disorder from major
depressive disorder. Journal of psychiatric research 2021;134:48-56.
26. Barrett A, Evans I, Frolov A, Britton G, Pellet-Many C, Yamaji M,
Mehta V, et al. A crucial role for DOK1 in PDGF-BB-stimulated glioma
cell invasion through p130Cas and Rap1 signalling. Journal of cell
science 2014;127:2647-2658.
27. Nissen L, Cao R, Hedlund E, Wang Z, Zhao X, Wetterskog D, Funa K, et
al. Angiogenic factors FGF2 and PDGF-BB synergistically promote murine
tumor neovascularization and metastasis. The Journal of clinical
investigation 2007;117:2766-2777.
28. Zhang S, Ma L, Zhao J, You S, Ma X, Ye X, Liu T. The Phenylethanol
Glycoside Liposome Inhibits PDGF-Induced HSC Activation via Regulation
of the FAK/PI3K/Akt Signaling Pathway. Molecules (Basel, Switzerland)
2019;24.
29. Feng X, Chi G, Wang H, Gao Y, Chen Q, Ru Y, Luo Z, et al. IL-37
suppresses the sustained hepatic IFN-γ/TNF-α production and T
cell-dependent liver injury. International immunopharmacology
2019;69:184-193.
30. Shen X, Guo H, Xu J, Wang J. Inhibition of lncRNA HULC improves
hepatic fibrosis and hepatocyte apoptosis by inhibiting the MAPK
signaling pathway in rats with nonalcoholic fatty liver disease. J Cell
Physiol 2019;234:18169-18179.
31. Irungbam K, Roderfeld M, Glimm H, Hempel F, Schneider F, Hehr L,
Glebe D, et al. Cholestasis impairs hepatic lipid storage via AMPK and
CREB signaling in hepatitis B virus surface protein transgenic mice.
Laboratory investigation; a journal of technical methods and pathology
2020;100:1411-1424.
32. Gu L, Tao X, Xu Y, Han X, Qi Y, Xu L, Yin L, et al. Dioscin
alleviates BDL- and DMN-induced hepatic fibrosis via Sirt1/Nrf2-mediated
inhibition of p38 MAPK pathway. Toxicology and applied pharmacology
2016;292:19-29.
33. Jin Z, Liu S, Zhan Q, Shao X, Ma J, Pan L. Decoy receptor 3
alleviates hepatic fibrosis through suppressing inflammation activated
by NF-κB signaling pathway. Advances in clinical and experimental
medicine : official organ Wroclaw Medical University 2018;27:441-447.
34. Li X, Zhang H, Pan L, Zou H, Miao X, Cheng J, Wu Y. Puerarin
alleviates liver fibrosis via inhibition of the ERK1/2 signaling pathway
in thioacetamide-induced hepatic fibrosis in rats. Experimental and
therapeutic medicine 2019;18:133-138.
35. Cao S, Zheng B, Chen T, Chang X, Yin B, Huang Z, Shuai P, et al.
Semen Brassicae ameliorates hepatic fibrosis by regulating transforming
growth factor-β1/Smad, nuclear factor-κB, and AKT signaling pathways in
rats. Drug design, development and therapy 2018;12:1205-1213.
36. Cao G, Zhu R, Jiang T, Tang D, Kwan H, Su T. Danshensu, a novel
indoleamine 2,3-dioxygenase1 inhibitor, exerts anti-hepatic fibrosis
effects via inhibition of JAK2-STAT3 signaling. Phytomedicine :
international journal of phytotherapy and phytopharmacology
2019;63:153055.
37. Hosui A, Kimura A, Yamaji D, Zhu B, Na R, Hennighausen L. Loss of
STAT5 causes liver fibrosis and cancer development through increased
TGF-{beta} and STAT3 activation. The Journal of experimental medicine
2009;206:819-831.
38. Tawfik A, Amin A, Yousef M, El-Sayd N, Elashry H, Elkadeem M,
Abd-Elsalam S. IL-1α correlates with severity of hepatitis C
virus-related liver diseases. Journal of inflammation research
2018;11:289-295.
39. Prystupa A, Kiciński P, Sak J, Boguszewska-Czubara A,
Toruń-Jurkowska A, Załuska W. Proinflammatory Cytokines (IL-1α, IL-6)
and Hepatocyte Growth Factor in Patients with Alcoholic Liver Cirrhosis.
Gastroenterology research and practice 2015;2015:532615.
40. Batsaikhan B, Lu M, Yeh M, Huang C, Huang C, Lin Z, Chen S, et al.
Elevated interleukin-4 levels predicted advanced fibrosis in chronic
hepatitis C. Journal of the Chinese Medical Association : JCMA
2019;82:277-281.
41. Xia C, Zhu W, Huang C, Lou G, Ye B, Chen F, Chen Z, et al. Genetic
polymorphisms of interleukin-6 influence the development of hepatitis B
virus-related liver cirrhosis in the Han Chinese population. Infection,
genetics and evolution : journal of molecular epidemiology and
evolutionary genetics in infectious diseases 2020;84:104331.
42. Guo X, Cen Y, Wang J, Jiang H. CXCL10-induced IL-9 promotes liver
fibrosis via Raf/MEK/ERK signaling pathway. Biomedicine &
pharmacotherapy = Biomedecine & pharmacotherapie 2018;105:282-289.
43. Li J, Xue J, Wang D, Dai X, Sun Q, Xiao T, Wu L, et al. Regulation
of gasdermin D by miR-379-5p is involved in arsenite-induced activation
of hepatic stellate cells and in fibrosis via secretion of IL-1β from
human hepatic cells. Metallomics : integrated biometal science
2019;11:483-495.
44. Yao L, Xing S, Fu X, Song H, Wang Z, Tang J, Zhao Y. Association
between interleukin-10 gene promoter polymorphisms and susceptibility to
liver cirrhosis. International journal of clinical and experimental
pathology 2015;8:11680-11684.
45. Wong S, Ting Y, Yong Y, Tan H, Barathan M, Riazalhosseini B, Bee C,
et al. Chronic inflammation involves CCL11 and IL-13 to facilitate the
development of liver cirrhosis and fibrosis in chronic hepatitis B virus
infection. Scandinavian journal of clinical and laboratory investigation
2021:1-13.
46. Swidnicka-Siergiejko A, Wereszczynska-Siemiatkowska U, Siemiatkowski
A, Wasielica-Berger J, Janica J, Mroczko B, Dabrowski A. The imbalance
of peripheral interleukin-18 and transforming growth factor-β1 levels in
patients with cirrhosis and esophageal varices. Cytokine
2019;113:440-445.
47. Mikadze I, Vashakidze E. The serum level of interleukin-12 among
patients with HCV infection. Georgian medical news 2011:40-45.
48. Jeong W, Kim J, Bazer FW, Song G, Kim J. Stimulatory effects of
interleukin-1 beta on development of porcine uterine epithelial cell are
mediated by activation of the ERK1/2 MAPK cell signaling cascade. Mol
Cell Endocrinol 2016;419:225-234.
Table 1. Effects of BDL or TAA on the liver fibrosis in rats